Nathaniel T. Bradley

Nathaniel T. Bradley, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Datavault AI Inc. and Parallax Health Sciences, Inc. Between 30 September 2019 and 3 August 2026, the trades on record add up to 24 filings.

The open-market side counts 1 purchase for €92k alongside 7 sales for €207k. Taken together, the sales exceed the purchases by €115k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 9 share grants. Since January 2026: no purchases and 1 sale on the market.

The newest entry dates from 5 August 2026: a transaction, in Datavault AI Inc. The last purchase on record was published on 19 November 2019, which is 2,530 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.